This is substantiated by studies showing that IFN-γ and poly (I:C) pre-treatment can enhance MSCs therapeutic efficacy in dextran sodium sulfate-induced colitis in mice (Lim et al., 2021). This evidence concerns the gene IFNG and colitis.